West Coast Financial »

Halozyme Therapeutics shares owned by West Coast Financial

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by West Coast Financial from 13F filings

Historical chart of West Coast Financial investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by West Coast Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by West Coast Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.1M 72k 57.24

More positions owned by West Coast Financial

Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Apple (AAPL)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Ishares Tr Mbs Etf (MBB)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Mastercard Incorporated Cl A (MA)
Amphenol Corp Cl A (APH)
Public Storage (PSA)
Marsh & McLennan Companies (MMC)
W.W. Grainger (GWW)
Pepsi (PEP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for West Coast Financial

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics